The clinical features and prognosis of mumps-associated hearing loss: a retrospective, multi-institutional investigation in Japan

Shinya Morita, Keishi Fujiwara, Atsushi Fukuda, Satoshi Fukuda, Shin ya Nishio, Ryosuke Kitoh, Naohito Hato, Tetsuo Ikezono, Kotaro Ishikawa, Kimitaka Kaga, Atsushi Matsubara, Tatsuo Matsunaga, Takaaki Murata, Yasushi Naito, Kazunori Nishizaki, Kaoru Ogawa, Hajime Sano, Hiroaki Sato, Michihiko Sone, Mikio SuzukiHaruo Takahashi, Tetsuya Tono, Hiroshi Yamashita, Tatsuya Yamasoba, Shin ichi Usami

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Conclusions: The majority of hearing loss due to mumps presents as unilateral profound sensorineural hearing loss, which is refractory to treatment. In rare cases of bilateral total deafness, cochlear implants were beneficial for speech perception. Vaccination against mumps is recommended to prevent mumps-associated hearing loss. Objective: The objective of this study is to investigate the clinical characteristics of hearing loss due to mumps and to evaluate hearing outcomes. Subjects and methods: The clinical parameters were analyzed under a retrospective multi-institutional study design in patients diagnosed with hearing loss due to mumps at the Otolaryngology departments of 19 hospitals between 1987 and 2016. Results: Sixty-seven patients with hearing loss due to mumps were enrolled. The study population consisted of 35 males and 32 females, ranging in age from 1 to 54, with a median age of 9.5 years. Sixty-three patients presented with unilateral, and 4 with bilateral hearing loss. Profound hearing loss was observed in 65 ears. Only one ear with severe hearing loss showed complete recovery. Four patients with bilateral hearing loss received cochlear implant surgery. Most of the patients with hearing loss due to mumps had no history of vaccination.

Original languageEnglish
Pages (from-to)1-4
Number of pages4
JournalActa Oto-Laryngologica
DOIs
Publication statusAccepted/In press - 2017 Feb 22

Fingerprint

Mumps
Hearing Loss
Japan
Bilateral Hearing Loss
Cochlear Implants
Deafness
Ear
Vaccination
Speech Perception
Sensorineural Hearing Loss
Hospital Departments
Otolaryngology
Hearing
Population

Keywords

  • cochlear implant
  • deafness
  • hearing loss
  • Mumps
  • outcome

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

The clinical features and prognosis of mumps-associated hearing loss : a retrospective, multi-institutional investigation in Japan. / Morita, Shinya; Fujiwara, Keishi; Fukuda, Atsushi; Fukuda, Satoshi; Nishio, Shin ya; Kitoh, Ryosuke; Hato, Naohito; Ikezono, Tetsuo; Ishikawa, Kotaro; Kaga, Kimitaka; Matsubara, Atsushi; Matsunaga, Tatsuo; Murata, Takaaki; Naito, Yasushi; Nishizaki, Kazunori; Ogawa, Kaoru; Sano, Hajime; Sato, Hiroaki; Sone, Michihiko; Suzuki, Mikio; Takahashi, Haruo; Tono, Tetsuya; Yamashita, Hiroshi; Yamasoba, Tatsuya; Usami, Shin ichi.

In: Acta Oto-Laryngologica, 22.02.2017, p. 1-4.

Research output: Contribution to journalArticle

Morita, S, Fujiwara, K, Fukuda, A, Fukuda, S, Nishio, SY, Kitoh, R, Hato, N, Ikezono, T, Ishikawa, K, Kaga, K, Matsubara, A, Matsunaga, T, Murata, T, Naito, Y, Nishizaki, K, Ogawa, K, Sano, H, Sato, H, Sone, M, Suzuki, M, Takahashi, H, Tono, T, Yamashita, H, Yamasoba, T & Usami, SI 2017, 'The clinical features and prognosis of mumps-associated hearing loss: a retrospective, multi-institutional investigation in Japan', Acta Oto-Laryngologica, pp. 1-4. https://doi.org/10.1080/00016489.2017.1290826
Morita, Shinya ; Fujiwara, Keishi ; Fukuda, Atsushi ; Fukuda, Satoshi ; Nishio, Shin ya ; Kitoh, Ryosuke ; Hato, Naohito ; Ikezono, Tetsuo ; Ishikawa, Kotaro ; Kaga, Kimitaka ; Matsubara, Atsushi ; Matsunaga, Tatsuo ; Murata, Takaaki ; Naito, Yasushi ; Nishizaki, Kazunori ; Ogawa, Kaoru ; Sano, Hajime ; Sato, Hiroaki ; Sone, Michihiko ; Suzuki, Mikio ; Takahashi, Haruo ; Tono, Tetsuya ; Yamashita, Hiroshi ; Yamasoba, Tatsuya ; Usami, Shin ichi. / The clinical features and prognosis of mumps-associated hearing loss : a retrospective, multi-institutional investigation in Japan. In: Acta Oto-Laryngologica. 2017 ; pp. 1-4.
@article{8379eb80c283444399c8d4c63c170a10,
title = "The clinical features and prognosis of mumps-associated hearing loss: a retrospective, multi-institutional investigation in Japan",
abstract = "Conclusions: The majority of hearing loss due to mumps presents as unilateral profound sensorineural hearing loss, which is refractory to treatment. In rare cases of bilateral total deafness, cochlear implants were beneficial for speech perception. Vaccination against mumps is recommended to prevent mumps-associated hearing loss. Objective: The objective of this study is to investigate the clinical characteristics of hearing loss due to mumps and to evaluate hearing outcomes. Subjects and methods: The clinical parameters were analyzed under a retrospective multi-institutional study design in patients diagnosed with hearing loss due to mumps at the Otolaryngology departments of 19 hospitals between 1987 and 2016. Results: Sixty-seven patients with hearing loss due to mumps were enrolled. The study population consisted of 35 males and 32 females, ranging in age from 1 to 54, with a median age of 9.5 years. Sixty-three patients presented with unilateral, and 4 with bilateral hearing loss. Profound hearing loss was observed in 65 ears. Only one ear with severe hearing loss showed complete recovery. Four patients with bilateral hearing loss received cochlear implant surgery. Most of the patients with hearing loss due to mumps had no history of vaccination.",
keywords = "cochlear implant, deafness, hearing loss, Mumps, outcome",
author = "Shinya Morita and Keishi Fujiwara and Atsushi Fukuda and Satoshi Fukuda and Nishio, {Shin ya} and Ryosuke Kitoh and Naohito Hato and Tetsuo Ikezono and Kotaro Ishikawa and Kimitaka Kaga and Atsushi Matsubara and Tatsuo Matsunaga and Takaaki Murata and Yasushi Naito and Kazunori Nishizaki and Kaoru Ogawa and Hajime Sano and Hiroaki Sato and Michihiko Sone and Mikio Suzuki and Haruo Takahashi and Tetsuya Tono and Hiroshi Yamashita and Tatsuya Yamasoba and Usami, {Shin ichi}",
year = "2017",
month = "2",
day = "22",
doi = "10.1080/00016489.2017.1290826",
language = "English",
pages = "1--4",
journal = "Acta Oto-Laryngologica",
issn = "0001-6489",
publisher = "Informa Healthcare",

}

TY - JOUR

T1 - The clinical features and prognosis of mumps-associated hearing loss

T2 - a retrospective, multi-institutional investigation in Japan

AU - Morita, Shinya

AU - Fujiwara, Keishi

AU - Fukuda, Atsushi

AU - Fukuda, Satoshi

AU - Nishio, Shin ya

AU - Kitoh, Ryosuke

AU - Hato, Naohito

AU - Ikezono, Tetsuo

AU - Ishikawa, Kotaro

AU - Kaga, Kimitaka

AU - Matsubara, Atsushi

AU - Matsunaga, Tatsuo

AU - Murata, Takaaki

AU - Naito, Yasushi

AU - Nishizaki, Kazunori

AU - Ogawa, Kaoru

AU - Sano, Hajime

AU - Sato, Hiroaki

AU - Sone, Michihiko

AU - Suzuki, Mikio

AU - Takahashi, Haruo

AU - Tono, Tetsuya

AU - Yamashita, Hiroshi

AU - Yamasoba, Tatsuya

AU - Usami, Shin ichi

PY - 2017/2/22

Y1 - 2017/2/22

N2 - Conclusions: The majority of hearing loss due to mumps presents as unilateral profound sensorineural hearing loss, which is refractory to treatment. In rare cases of bilateral total deafness, cochlear implants were beneficial for speech perception. Vaccination against mumps is recommended to prevent mumps-associated hearing loss. Objective: The objective of this study is to investigate the clinical characteristics of hearing loss due to mumps and to evaluate hearing outcomes. Subjects and methods: The clinical parameters were analyzed under a retrospective multi-institutional study design in patients diagnosed with hearing loss due to mumps at the Otolaryngology departments of 19 hospitals between 1987 and 2016. Results: Sixty-seven patients with hearing loss due to mumps were enrolled. The study population consisted of 35 males and 32 females, ranging in age from 1 to 54, with a median age of 9.5 years. Sixty-three patients presented with unilateral, and 4 with bilateral hearing loss. Profound hearing loss was observed in 65 ears. Only one ear with severe hearing loss showed complete recovery. Four patients with bilateral hearing loss received cochlear implant surgery. Most of the patients with hearing loss due to mumps had no history of vaccination.

AB - Conclusions: The majority of hearing loss due to mumps presents as unilateral profound sensorineural hearing loss, which is refractory to treatment. In rare cases of bilateral total deafness, cochlear implants were beneficial for speech perception. Vaccination against mumps is recommended to prevent mumps-associated hearing loss. Objective: The objective of this study is to investigate the clinical characteristics of hearing loss due to mumps and to evaluate hearing outcomes. Subjects and methods: The clinical parameters were analyzed under a retrospective multi-institutional study design in patients diagnosed with hearing loss due to mumps at the Otolaryngology departments of 19 hospitals between 1987 and 2016. Results: Sixty-seven patients with hearing loss due to mumps were enrolled. The study population consisted of 35 males and 32 females, ranging in age from 1 to 54, with a median age of 9.5 years. Sixty-three patients presented with unilateral, and 4 with bilateral hearing loss. Profound hearing loss was observed in 65 ears. Only one ear with severe hearing loss showed complete recovery. Four patients with bilateral hearing loss received cochlear implant surgery. Most of the patients with hearing loss due to mumps had no history of vaccination.

KW - cochlear implant

KW - deafness

KW - hearing loss

KW - Mumps

KW - outcome

UR - http://www.scopus.com/inward/record.url?scp=85016004951&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016004951&partnerID=8YFLogxK

U2 - 10.1080/00016489.2017.1290826

DO - 10.1080/00016489.2017.1290826

M3 - Article

C2 - 28338374

AN - SCOPUS:85016004951

SP - 1

EP - 4

JO - Acta Oto-Laryngologica

JF - Acta Oto-Laryngologica

SN - 0001-6489

ER -